Corporate Banner
Satellite Banner
Technology Networks Header
Monday, January 26, 2015
Technology Networks
 
Register | Sign in
Home Page>News

  News Archive

Improved Mouse Model will Accelerate Research on Potential Ebola Vaccines, Treatments
Thursday, October 30, 2014
UNC researchers and colleagues are the first to develop a mouse model that more accurately reflects human disease symptoms; they found a single gene crucial for disease severity.

Team Discovers How Microbes Build a Powerful Antibiotic
Wednesday, October 29, 2014
Researchers discovery opens up new avenues of research into thousands of similar molecules.

Bavarian Nordic Enters Licensing and Supply Agreement with Janssen
Tuesday, October 28, 2014
Bavarian Nordic will scale up and is targeting to manufacture more than 1 million doses of the prophylactic vaccine in 2015 for clinical trials and emergency use in the current Ebola outbreak in West Africa.

BioSilta Establishes Cambridgeshire HQ
Tuesday, October 28, 2014
BioSilta Ltd has completed the set-up of operational and commercial headquarters in St Ives, Cambridgeshire, UK.

CSL to Acquire Novartis Influenza Vaccine Business
Monday, October 27, 2014
CSL to acquire Novartis influenza vaccines business, including development pipeline, for USD 275 million.

TAP Biosystems and Merck & Co., Inc. Double Triumph at BPI 2014 Awards
Monday, October 27, 2014
“Best Collaboration” and “Best Technology Application — Upstream” Awards acknowledges ambr250 mini bioreactor system as an exceptional technology.

Self-Assembly of Layered Membranes
Monday, October 27, 2014
Scientists used self-assembly under controlled conditions to create a membrane consisting of layers with distinctly different structures.

Lilly, Zymeworks Expand Strategic Licensing and Collaboration Agreement
Friday, October 24, 2014
Zymeworks Inc. and Eli Lilly and Company are expanding their existing licensing and collaboration agreement.

NIH Begins Early Human Clinical Trial of VSV Ebola Vaccine
Thursday, October 23, 2014
Human testing of a second investigational Ebola vaccine candidate is under way at the National Institutes of Health’s Clinical Center in Bethesda, Maryland.

<< 4 5 6 7 8 9 10 >>
Showing Results 61 - 70 of 1200
Skyscraper Banner
SELECTBIO Market Reports
LabTube - Videos for the Scientific Community
eposters - The Online Journal of Scientific Posters
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn